News and Announcements
Actinogen Medical Provides Quarterly Newsletter Focusing on Brain Awareness Week
- Published March 16, 2017 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
Actinogen Medical is pleased to provide its latest quarterly newsletter which focuses on Brain Awareness Week (13-19 Mar 2017) – a global campaign to increase public awareness of the progress and benefits of brain research.
KEY TAKEAWAYS:
- One-in-three people will develop Alzheimer’s disease by the time they are 85 and available health budgets cannot cope with managing this disease – it already costs US$250 billion annually in the US alone.
- Dr Bill Ketelbey reflects on his own personal journey to seek a cure for Alzheimer’s disease and the reasons why he joined Actinogen.
- Recent key Australian research may have provided an important clue to how best to develop a new treatment for Alzheimer’s disease and this is why Actinogen Medical’s XanADu program is so keenly watched.
Please Click below for the full Quarterly Investor Newsletter.